Hepatitis B surface antigen (HBsAg) prevalence in Uganda
Uganda: Hepatitis B surface antigen (HBsAg) prevalence was 0.3% in 2024. βΌ Falling
Latest (2024)
0.3%
Change on year
down 25.0%
World rank
71st
of 192 countries
All-time high
0.5%
in 2015
All-time low
0.3%
in 2018
Years of data
10
2015β2024
Hepatitis B surface antigen (HBsAg) prevalence in Uganda, 2015β2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Uganda is 0.3%, measured in 2024. That is the lowest value across all 10 years on record.
The figure is down 25.0% on the previous year and down 40.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Uganda peaked at 0.5% in 2015 and was at its lowest, 0.3%, in 2018.
Uganda ranks 71st of 192 countries on this measure, in the middle of the range.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.4% | 0.3% | 0.5% | 5 |
| 2020s | 0.4% | 0.3% | 0.4% | 5 |
Countries ranked near Uganda
- 71 Turkmenistan 0.3% compare
- 71 Afghanistan 0.3% compare
- 71 Azerbaijan 0.3% compare
- 71 Bosnia and Herzegovina 0.3% compare
- 71 Haiti 0.3% compare
- 71 Sri Lanka 0.3% compare
- 71 Republic of Moldova 0.3% compare
- 71 Mongolia 0.3% compare
- 71 Malawi 0.3% compare
- 71 Rwanda 0.3% compare
More health data for Uganda
- Un projection of annual infant deaths, annual growth rate -2.2 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.34 % change on previous year (2090)
- Heat deaths vs projected death rates 853.6 (2090)
- Un projection of annual infant deaths 6,666 (2100)
- Population, male, annual growth rate 2.78 % change on previous year (2025)
- Population, male, per unit of GDP 0.0004 units per US$ of GDP (2025)
- Population, male, per capita 0.4962 units per person (2025)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 464,951 (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Uganda?
- Hepatitis b surface antigen (hbsag) prevalence in Uganda was 0.3% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Uganda?
- The highest recorded value was 0.5% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Uganda?
- The lowest recorded value was 0.3% in 2018.
- How does Uganda rank for hepatitis b surface antigen (hbsag) prevalence?
- Uganda ranks 71st out of 192 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Uganda?
- Over the last ten years it is down 40.0%. The long-run trend across the full record is falling.
- Where does this Uganda data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV Β· JSON β 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).